Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Navigator Medicines operate as a biotech company.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.
Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Corsera Health develops preventive RNA interference medicines that reduces cardiovascular disease risk before long-term damage occurs.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.
PACT designs Elegant materials produced in tune with the planet earth.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Plant-based Mining Biotech
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Forbion Capital Partners has invested in 124 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Forbion Capital Partners's top investment sectors include Biotechnology, Therapeutics, Medical, Life Science, Health Care. The firm invests across 16 different industry categories.
Among tracked funding rounds, Dyne Therapeutics received $375.1M in a Post-IPO Equity round. Forbion Capital Partners's total known invested capital is $12.0B.
Forbion Capital Partners's average investment size is $96.6M across its portfolio of 124 companies.
Recent Forbion Capital Partners portfolio additions include OMass Therapeutics, Navigator Medicines, Orbis Medicines, Sling Therapeutics, Solstice Oncology. These companies were founded in 2020 or later.